Background: Chronic hepatitis B (CHB) remains a significant health concern, especially in low- and middle-income countries. Some CHB patients with normal or mildly elevated ALT may have advanced liver fibrosis, which often goes undetected. Objective: The aim of this study was to assess the prevalence of significant fibrosis and the diagnostic accuracy of serum markers in CHB patients with ALT
Key words: Chronic hepatitis B, liver fibrosis, APRI, platelet count, non-invasive biomarkers, Vietnam.
|